Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeev Blumenfeld

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Expert Review of Endocrinology & Metabolism|February 21, 2019
Preservation of ovarian function and fertility despite gonadotoxic chemotherapyZeev Blumenfeld
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
ZORO study: discrepancy between the conclusion and the resultsZeev Blumenfeld
Women'S Health (London, England)|November 2, 2011
Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogsZeev Blumenfeld
Hematological Oncology|June 11, 2010
Fertility preservation after chemotherapy for Hodgkin lymphomaZeev Blumenfeld
Journal of Women'S Health (2002)|August 28, 2009
Ovarian function preservation by GnRH agonists during chemotherapyZeev Blumenfeld
Frontiers in Endocrinology|May 5, 2020
What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?Zeev Blumenfeld
Arthritis and Rheumatism|January 11, 2003
Comment on steroid hormones and disease activity during pregnancy in systemic lupus erythematosusZeev Blumenfeld
Arthritis and Rheumatism|October 2, 2002
Treatment with gonadotropin-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et alZeev Blumenfeld
Human Reproduction (Oxford, England)|July 21, 2004
Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocereZeev Blumenfeld
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Gonadotropin-releasing hormone agonist for preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancerZeev Blumenfeld
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Expert Review of Endocrinology & Metabolism|February 21, 2019
Preservation of ovarian function and fertility despite gonadotoxic chemotherapyZeev Blumenfeld
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
ZORO study: discrepancy between the conclusion and the resultsZeev Blumenfeld
Women'S Health (London, England)|November 2, 2011
Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogsZeev Blumenfeld
Hematological Oncology|June 11, 2010
Fertility preservation after chemotherapy for Hodgkin lymphomaZeev Blumenfeld
Journal of Women'S Health (2002)|August 28, 2009
Ovarian function preservation by GnRH agonists during chemotherapyZeev Blumenfeld
Frontiers in Endocrinology|May 5, 2020
What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?Zeev Blumenfeld
Arthritis and Rheumatism|January 11, 2003
Comment on steroid hormones and disease activity during pregnancy in systemic lupus erythematosusZeev Blumenfeld
Arthritis and Rheumatism|October 2, 2002
Treatment with gonadotropin-releasing hormone agonists and prevention of multiple gestations in lupus or antiphospholipid syndrome patients undergoing in vitro fertilization: comment on the article by Guballa et alZeev Blumenfeld
Human Reproduction (Oxford, England)|July 21, 2004
Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocereZeev Blumenfeld
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Gonadotropin-releasing hormone agonist for preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancerZeev Blumenfeld
Pageof 11